| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0003000 | Intron-Intron | chr3:171781394-171782329 | chr3:172063604-172064539 | 936 nt | 0.4252 |
| hsa_FNDC3B_0003100 | Intron-Exon-Intron | chr3:171784093-171851336 | chr3:172066303-172133546 | 76 nt | 0.4079 |
| hsa_FNDC3B_0003200 | Intron-Intron | chr3:171791756-171792830 | chr3:172073966-172075040 | 1075 nt | 0.4028 |
| hsa_chr3_0365400 | Intergenic-Intergenic | chr3:171792587-171794000 | chr3:172074797-172076210 | 1414 nt | 0.3663 |
| hsa_FNDC3B_0003300 | Intron-Exon-Intron | chr3:171796537-171830380 | chr3:172078747-172112590 | 250 nt | 0.4000 |
| hsa_FNDC3B_0003400 | Intron-Exon-Intron | chr3:171796537-171969331 | chr3:172078747-172251541 | 250 nt | 0.4080 |
| hsa_FNDC3B_0003500 | Intron-Exon-Intron | chr3:171796651-171830380 | chr3:172078861-172112590 | 250 nt | 0.3800 |
| hsa_FNDC3B_0003800 | Intron-Intron | chr3:171797144-171799189 | chr3:172079354-172081399 | 219 nt | 0.4201 |
| hsa_FNDC3B_0003600 | Intron-Intron | chr3:171797144-171799505 | chr3:172079354-172081715 | 2362 nt | 0.3810 |
| hsa_FNDC3B_0003900 | Intron-Exon | chr3:171797144-171830335 | chr3:172079354-172112545 | 94 nt | 0.5000 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].